pregabalin News
Most Popular pregabalin Story
XenoPort, Glaxo say neuropathy drug flunks trial
Citing an unexpectedly high placebo response, XenoPort and GlaxoSmithKline reported this morning that their experimental therapy to treat numbness in diabetes patients failed a mid-stage trial. Read more...
Latest Headlines
- April 27, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
